Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001910901 | SCV002162366 | uncertain significance | not provided | 2024-12-19 | criteria provided, single submitter | clinical testing | This sequence change replaces valine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 68 of the CARD8 protein (p.Val68Leu). This variant is present in population databases (rs536212135, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with CARD8-related conditions. ClinVar contains an entry for this variant (Variation ID: 1391055). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV004039161 | SCV003682373 | uncertain significance | not specified | 2025-01-17 | criteria provided, single submitter | clinical testing | The c.352G>C (p.V118L) alteration is located in exon 4 (coding exon 4) of the CARD8 gene. This alteration results from a G to C substitution at nucleotide position 352, causing the valine (V) at amino acid position 118 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003401839 | SCV004103993 | uncertain significance | CARD8-related disorder | 2023-07-12 | criteria provided, single submitter | clinical testing | The CARD8 c.352G>C variant is predicted to result in the amino acid substitution p.Val118Leu. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.020% of alleles in individuals of European (Non-Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-48735749-C-G). At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |